Correlation Between Edgewise Therapeutics and PsyBio Therapeutics
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and PsyBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and PsyBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and PsyBio Therapeutics Corp, you can compare the effects of market volatilities on Edgewise Therapeutics and PsyBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of PsyBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and PsyBio Therapeutics.
Diversification Opportunities for Edgewise Therapeutics and PsyBio Therapeutics
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Edgewise and PsyBio is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and PsyBio Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PsyBio Therapeutics Corp and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with PsyBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PsyBio Therapeutics Corp has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and PsyBio Therapeutics go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and PsyBio Therapeutics
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.27 times more return on investment than PsyBio Therapeutics. However, Edgewise Therapeutics is 3.69 times less risky than PsyBio Therapeutics. It trades about -0.05 of its potential returns per unit of risk. PsyBio Therapeutics Corp is currently generating about -0.15 per unit of risk. If you would invest 3,481 in Edgewise Therapeutics on September 23, 2024 and sell it today you would lose (403.00) from holding Edgewise Therapeutics or give up 11.58% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 97.73% |
Values | Daily Returns |
Edgewise Therapeutics vs. PsyBio Therapeutics Corp
Performance |
Timeline |
Edgewise Therapeutics |
PsyBio Therapeutics Corp |
Edgewise Therapeutics and PsyBio Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Edgewise Therapeutics and PsyBio Therapeutics
The main advantage of trading using opposite Edgewise Therapeutics and PsyBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, PsyBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PsyBio Therapeutics will offset losses from the drop in PsyBio Therapeutics' long position.Edgewise Therapeutics vs. Fate Therapeutics | Edgewise Therapeutics vs. Sana Biotechnology | Edgewise Therapeutics vs. Caribou Biosciences | Edgewise Therapeutics vs. Arcus Biosciences |
PsyBio Therapeutics vs. Nova Mentis Life | PsyBio Therapeutics vs. HAVN Life Sciences | PsyBio Therapeutics vs. TC BioPharm plc | PsyBio Therapeutics vs. Opthea |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |